Medifast, Inc. (MED)
NYSE: MED · Real-Time Price · USD
10.60
-0.03 (-0.28%)
At close: Feb 23, 2026, 4:00 PM EST
10.62
+0.02 (0.19%)
After-hours: Feb 23, 2026, 7:00 PM EST

Medifast Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Feb '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
1091101887241,2532,424
Market Cap Growth
-35.38%-41.52%-74.09%-42.20%-48.30%5.36%
Enterprise Value
-47-51355891,2112,284
Last Close Price
10.6010.6817.6267.22109.01188.97
PE Ratio
--89.767.298.7314.78
Forward PE
---13.059.0313.75
PS Ratio
0.280.280.310.680.781.59
PB Ratio
0.550.550.893.608.0811.97
P/TBV Ratio
0.550.550.893.608.0811.97
P/FCF Ratio
87.5487.8811.035.137.0540.17
P/OCF Ratio
15.9315.997.674.916.4425.64
PEG Ratio
-0.550.550.550.550.55
EV/Sales Ratio
--0.060.550.761.50
EV/EBITDA Ratio
--1.264.226.1910.24
EV/EBIT Ratio
--2.304.666.5510.56
EV/FCF Ratio
--2.084.176.8137.85
Debt / Equity Ratio
0.050.050.080.110.170.16
Debt / EBITDA Ratio
2.172.170.490.150.130.14
Debt / FCF Ratio
8.568.560.950.160.150.54
Net Debt / Equity Ratio
-0.79-0.79-0.70-0.63-0.40-0.38
Net Debt / EBITDA Ratio
-5399.28-5399.28-5.21-0.92-0.31-0.34
Net Debt / FCF Ratio
-125.36-125.36-8.59-0.91-0.35-1.28
Asset Turnover
1.451.452.033.424.474.53
Inventory Turnover
3.533.533.253.423.073.41
Quick Ratio
3.893.892.531.630.620.65
Current Ratio
4.694.693.342.431.581.81
Return on Equity (ROE)
-9.13%-9.13%1.02%55.77%80.31%91.20%
Return on Assets (ROA)
-3.34%-3.34%3.24%25.24%32.33%40.08%
Return on Invested Capital (ROIC)
-29.67%-26.76%12.37%116.95%131.72%274.89%
Return on Capital Employed (ROCE)
-6.90%-6.90%7.00%58.10%105.40%94.60%
Earnings Yield
-17.08%-17.01%1.11%13.72%11.46%6.77%
FCF Yield
1.14%1.14%9.07%19.49%14.19%2.49%
Dividend Yield
---7.36%6.02%3.01%
Payout Ratio
--34.19%73.45%49.89%38.93%
Buyback Yield / Dilution
-0.16%-0.16%-0.39%3.15%4.55%0.31%
Total Shareholder Return
-0.16%-0.16%-0.39%10.51%10.56%3.32%
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q